aTYR PHARMA (ATYR) Receivables - Other (2019 - 2025)
aTYR PHARMA's Receivables - Other history spans 7 years, with the latest figure at $873000.0 for Q4 2025.
- For Q4 2025, Receivables - Other fell 49.71% year-over-year to $873000.0; the TTM value through Dec 2025 reached $873000.0, down 49.71%, while the annual FY2025 figure was $873000.0, 49.71% down from the prior year.
- Receivables - Other reached $873000.0 in Q4 2025 per ATYR's latest filing, down from $1.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $11.8 million in Q4 2022 to a low of $89000.0 in Q1 2021.
- Average Receivables - Other over 5 years is $1.6 million, with a median of $1.0 million recorded in 2025.
- Peak YoY movement for Receivables - Other: tumbled 89.17% in 2021, then soared 2606.9% in 2022.
- A 5-year view of Receivables - Other shows it stood at $435000.0 in 2021, then skyrocketed by 2606.9% to $11.8 million in 2022, then tumbled by 79.31% to $2.4 million in 2023, then dropped by 28.74% to $1.7 million in 2024, then tumbled by 49.71% to $873000.0 in 2025.
- Per Business Quant, the three most recent readings for ATYR's Receivables - Other are $873000.0 (Q4 2025), $1.0 million (Q3 2025), and $498000.0 (Q2 2025).